On November 25, 2024 Moleculin Biotech had Day Typical Price of 2.69. Typical Price is calculated as arithmetic average of the high, low and closing price for a given trading period.
On November 26 2024 Moleculin Biotech was traded for 2.62 at the closing time. The top price for the day was 2.72 and the lowest listed price was 2.50 . The trading volume for the day was 51.2 K. The trading history from November 26, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.13% . The trading delta at closing time against the current closing price is 2.64% .
The period considered in calculating typical price is a single trading day, however the typical price can also be applied to other time spans such as a week, month or year.
For every potential investor in Moleculin, whether a beginner or expert, Moleculin Biotech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Moleculin Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Moleculin. Basic forecasting techniques help filter out the noise by identifying Moleculin Biotech's price trends.
Moleculin Biotech Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Moleculin Biotech's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Moleculin Biotech's current price.
Market strength indicators help investors to evaluate how Moleculin Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Moleculin Biotech shares will generate the highest return on investment. By undertsting and applying Moleculin Biotech stock market strength indicators, traders can identify Moleculin Biotech entry and exit signals to maximize returns.
The analysis of Moleculin Biotech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Moleculin Biotech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting moleculin stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When running Moleculin Biotech's price analysis, check to measure Moleculin Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moleculin Biotech is operating at the current time. Most of Moleculin Biotech's value examination focuses on studying past and present price action to predict the probability of Moleculin Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moleculin Biotech's price. Additionally, you may evaluate how the addition of Moleculin Biotech to your portfolios can decrease your overall portfolio volatility.